| Source: |
| Type: |
| GALNT10 - Polypeptide N-Acetylgalactosaminyltransferase 10 Abbreviation: GALNT10 Type: Glycosyltransferase / O-GalNAc transferase Function: Initiates mucin-type O-linked glycosylation by transferring N-acetylgalactosamine (GalNAc) to serine or threonine residues of protein substrates. GALNT10 can alter protein secretion, signaling, cell adhesion, epithelial-mesenchymal transition, and tumor-microenvironment interactions through substrate-specific O-glycosylation. Cancer: ↑ Increased GALNT10 activity/expression can promote tumor progression and metastasis. In ovarian cancer, GALNT10 promotes EMT and metastatic vascular remodeling through O-glycosylation of IGFBP7, enhancing its secretion and subsequent CD93-mediated endothelial signaling. |
| 7266- | Gink, | Ginkgo biloba derivative ginkgetin inhibits breast cancer growth by regulating the miRNA-122-5p/GALNT10 axis |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-453 | - | in-vitro, | BC, | MCF7 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1617 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid